Here, we describe a novel mechanism leading to TIAM2 overexpression in ovarian and endometrial carcinoma, that involves formation of a new fusion transcript transcribed from a nearby promoter that is highly active in these tissue types. The gene discussed is TIAM2; the disease is endometrial carcinoma.